相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Nosocomial methicillin-resistant Staphylococcus aureus (MRSA) bacteremia in Taiwan: Mortality analyses and the impact of vancomycin, MIC=2 mg/L, by the broth microdilution method
Jiun-Ling Wang et al.
BMC INFECTIOUS DISEASES (2010)
Reduced Vancomycin Susceptibility in Staphylococcus aureus, Including Vancomycin-Intermediate and Heterogeneous Vancomycin-Intermediate Strains: Resistance Mechanisms, Laboratory Detection, and Clinical Implications
Benjamin P. Howden et al.
CLINICAL MICROBIOLOGY REVIEWS (2010)
Paradoxical Relationship between the Clinical Outcome of Staphylococcus aureus Bacteremia and the Minimum Inhibitory Concentration of Vancomycin
James Price et al.
CLINICAL INFECTIOUS DISEASES (2009)
Community-associated versus healthcare-associated methicillin-resistant Staphylococcus aureus bacteraemia: a 10-year retrospective review
J. O. Robinson et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2009)
Vancomycin MIC plus Heteroresistance and Outcome of Methicillin-Resistant Staphylococcus aureus Bacteremia: Trends over 11 Years
Adina C. Musta et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2009)
Persistent Staphylococcus aureus bacteremia: Incidence and outcome trends over time
Riad Khatib et al.
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES (2009)
Relationship between vancomycin MIC and failure among patients with methicillin-resistant Staphylococcus aureus bacteremia treated with vancomycin
T. P. Lodise et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Influence of vancomycin minimum inhibitory concentration on the treatment of methicillin-resistant Staphylococcus aureus bacteremia
Alex Soriano et al.
CLINICAL INFECTIOUS DISEASES (2008)
Comparison of both clinical features and mortality risk associated with bacteremia due to community-acquired methicillin-resistant Staphylococcus aureus and methicillin-susceptible S. aureus
Jiun-Ling Wang et al.
CLINICAL INFECTIOUS DISEASES (2008)
Management of methicillin-resistant Staphylococcus aureus bacteremia
Sara E. Cosgrove et al.
CLINICAL INFECTIOUS DISEASES (2008)
Comparison of method-specific vancomycin minimum inhibitory concentration values and their predictability for treatment outcome of meticillin-resistant Staphylococcus aureus (MRSA) infections
Donald I. Hsu et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2008)
Predictors of high vancomycin MIC values among patients with methicillin-resistant Staphylococcus aureus bacteraemia
T. P. Lodise et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2008)
Staphylococcus aureus bloodstream infections:: The association between age and mortality and functional status
Preeti N. Malani et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2008)
Microbiological effects of prior vancomycin use in patients with methicillin-resistant Staphylococcus aureus bacteraemia
Pamela A. Moise et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2008)
Outcome of vancomycin treatment in patients with methicillin-susceptible Staphylococcus aureus bacteremia
Sung-Han Kim et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Impact of empirical-therapy selection on outcomes of intravenous drug users with infective endocarditis caused by methicillin-susceptible Staphylococcus aureus
Thomas P. Lodise et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Comparison of mortality risk associated with bacteremia due to methicillin-resistant and methicillin-susceptible Staphylococcus aureus
Simone Shurland et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2007)
Use of vancomycin or first-generation cephalosporins for the treatment of hemodialysis-dependent patients with methicillin-susceptible Staphylococcus aureus bacteremia
Martin E. Stryjewski et al.
CLINICAL INFECTIOUS DISEASES (2007)
High-dose vancomycin therapy for methicillin-resistant Staphylococcus aureus infections -: Efficacy and toxicity
Levita K. Hidayat et al.
ARCHIVES OF INTERNAL MEDICINE (2006)
Contour-clamped homogeneous electric field electrophoresis of Staphylococcus aureus
Frances G. O'Brien et al.
NATURE PROTOCOLS (2006)
The role of vancomycin in the persistence or recurrence of Staphylococcus aureus bacteraemia
Y Siegman-Igra et al.
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES (2005)
Accessory gene regulator group II polymorphism in methicillin-resistant Staphylococcus aureus is predictive of failure of vancomycin therapy
PA Moise-Broder et al.
CLINICAL INFECTIOUS DISEASES (2004)
Relationship of MIC and bactericidal activity to efficacy of vancomycin for treatment of methicillin-resistant Staphylococcus aureus bacteremia
G Sakoulas et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2004)
A prospective multicenter study of Staphylococcus aureus bacteremia -: Incidence of endocarditis, risk factors for mortality, and clinical impact of methicillin resistance
FY Chang et al.
MEDICINE (2003)
Staphylococcus aureus bacteremia -: Recurrence and the impact of antibiotic treatment in a prospective multicenter study
FY Chang et al.
MEDICINE (2003)
Treatment and outcome of Staphylococcus aureus bacteremia -: A prospective study of 278 cases
AG Jensen et al.
ARCHIVES OF INTERNAL MEDICINE (2002)
分享论文
